Identification of two of these actionable variants (RBM20 and SDHB) led to screening that identified associated findings (evidence of DCM and papillary thyroid cancer, respectively) and may have a significant impact on these participants’ long-term health. This evidence concerns the gene SDHB and thyroid gland papillary carcinoma.